NCI-SPONSORED YEAR-ROUND SHANNON AWARD PROGRAM NIH GUIDE, Volume 25, Number 10, March 29, 1996 P.T. 34 Keywords: Grants Administration/Policy+ Cancer/Carcinogenesis National Cancer Institute The National Cancer Institute (NCI) announces that, with the permission of the Office of the Director, NIH, it has established an ongoing program to issue Shannon Awards (R55) on a three times yearly basis to supplement and expedite the annual NIH Shannon Award program, which is currently conducted as a single annual competition in the last quarter of each fiscal year. The NCI Shannon Award program will offer expedited funding for eligible applications that otherwise might wait up to nine months for the annual NIH Shannon competition, or for resubmission and review as full competing amended applications. Awardees will gain both immediate funding to begin important and innovative research projects; and, as has been the case for previous Shannon awards, are likely to have improved chances for obtaining subsequent research project grant (R01) support. The NCI Shannon Award program is conducted under the auspices of the authorities granted to the Director, NIH. Terms of award will be uniform with all other NIH Shannon Awards. R55 awards paid with NCI funds will be issued with the standard provisions of a 24-month single budget period at a maximum of $100,000 total cost, with indirect costs capped at a maximum of $20,000. Applicants do not submit requests for Shannon Awards. Instead, NCI program staff nominate for award previously reviewed eligible R01, R03, and R29 applications that are beyond the current NCI payline. After each of the three review cycles per year, Shannon Award nominations will be administratively reviewed by NCI according to standard review criteria, then submitted to the Office of Extramural Research, NIH, for expedited review and concurrence prior to funding. The NCI will use NCI funds to award R55 nominations that become eligible after each of the first two National Advisory Board rounds in each fiscal year. Such nominations cannot now be considered in a timely way, given the single annual summer date of the NIH-wide Shannon competition supported from the NIH Director's Discretionary Fund. The third round of the year will be submitted under the auspices of the current NIH-wide Shannon Award program. If the NIH is not able to hold a Shannon competition in a given year, NCI will extend its own program to all three application review rounds. The NCI is committed to offer funding for Shannon awards in numbers substantially higher than have previously been possible. It is anticipated that NCI will be able to commit approximately $3,000,000 to the NCI Shannon Award program in FY 96. NCI's continuation of this program in the future is contingent upon the availability of appropriated funds and applications of sufficient scientific merit. INQUIRIES For specific questions on this process, nominees may contact the NCI program director indicated on the original summary statement. General policy questions may be directed to: Marvin R. Kalt, Ph.D. Director, Division of Extramural Activities National Cancer Institute 6130 Executive Boulevard, Suite 600 - MSC 7405 Bethesda, MD 20892-7405 Email: KALTM@DEA.NCI.NIH.GOV Inquiries of a fiscal/administrative nature may be directed to: Ms. Catherine Blount Grants Administration Branch National Cancer Institute 6120 Executive Boulevard, Suite 243 Bethesda, MD 20892 Telephone: (301) 496-7800, ext. 262 .
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, RealPlayer, Video or Flash files, see Help Downloading Files. |